Skip to content
OpenCapital
Get started

Bolt Biotherapeutics, Inc. BOLT Q1 2026 earnings

Reported May 12, 2026 · Before market open

Revenue$26.0KMiss by $1.5M
EPS-$4.31Miss by $1.46
Revenue estimate$1.5M
EPS estimate-$2.85

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$500.0K
EPS estimate-$3.39

Versus estimates

Revenue

Q1 2026$26.0KMiss by $1.5M
Q4 2025$2.5MBeat by $1.8MQ3 2025$2.2MBeat by $1.3MQ2 2025$1.8MBeat by $958.2KQ1 2025$1.2MBeat by $454.5KQ4 2024$10.0KMiss by $780.0K

Diluted EPS

Q1 2026-$4.31Miss by $1.46
Q4 2025-$3.84Beat by $0.46Q3 2025-$3.72Beat by $1.35Q2 2025-$4.46Beat by $1.94Q1 2025-$5.80Beat by $1.00Q4 2024-$7.60In line

Ask the moment Bolt Biotherapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Bolt Biotherapeutics, Inc. report Q1 2026 earnings?
Bolt Biotherapeutics, Inc. (BOLT) reported Q1 2026 earnings on May 12, 2026 before market open.
What were Bolt Biotherapeutics, Inc.'s Q1 2026 revenue and EPS?
Bolt Biotherapeutics, Inc. reported revenue of $26.0K and eps of $-4.31 for Q1 2026.
Did Bolt Biotherapeutics, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $1.5M by $1.5M. EPS missed the consensus estimate of $-2.85 by $1.46.
How did Bolt Biotherapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 97.9% from $1.2M a year earlier and eps grew 25.7% from $-5.80.
Where can I find Bolt Biotherapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-219361) and the 10-Q periodic report (0001193125-26-219382) directly on SEC EDGAR. The filing index links above go to sec.gov.